EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions

Assia Tiane, Melissa Schepers, Rick A Reijnders, Lieve van Veggel, Sarah Chenine, Ben Rombaut, Emma Dempster, Catherine Verfaillie, Kobi Wasner, Anne Grünewald, Jos Prickaerts, Ehsan Pishva und 3 weitere

Acta Neuropathologica · 2023-08 · 146 (2) · 283-299

DOI: 10.1007/s00401-023-02596-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 07.06.2023. Verfasst von Assia Tiane und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, Fondation Charcot.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the progressive phase of multiple sclerosis (MS), the hampered differentiation capacity of oligodendrocyte precursor cells (OPCs) eventually results in remyelination failure. We have previously shown that DNA methylation of Id2/Id4 is highly involved in OPC differentiation and remyelination. In this study, we took an unbiased approach by determining genome-wide DNA methylation patterns within chronically demyelinated MS lesions and investigated how certain epigenetic signatures relate to OPC differentiation capacity. We compared genome-wide DNA methylation and transcriptional profiles between chronically demyelinated MS lesions and matched normal-appearing white matter (NAWM), making use of post-mortem brain tissue ( n = 9/group). DNA methylation differences that inversely correlated with mRNA expression of their corresponding genes were validated for their cell-type specificity in laser-captured OPCs using pyrosequencing. The CRISPR–dCas9-DNMT3a/TET1 system was used to epigenetically edit human-iPSC-derived oligodendrocytes to assess the effect on cellular differentiation. Our data show hypermethylation of CpGs within genes that cluster in gene ontologies related to myelination and axon ensheathment. Cell type-specific validation indicates a region-dependent hypermethylation of MBP , encoding for myelin basic protein, in OPCs obtained from white matter lesions compared to NAWM-derived OPCs. By altering the DNA methylation state of specific CpGs within the promotor region of MBP , using epigenetic editing, we show that cellular differentiation and myelination can be bidirectionally manipulated using the CRISPR–dCas9-DNMT3a/TET1 system in vitro. Our data indicate that OPCs within chronically demyelinated MS lesions acquire an inhibitory phenotype, which translates into hypermethylation of crucial myelination-related genes. Altering the epigenetic status of MBP can restore the differentiation capacity of OPCs and possibly boost (re)myelination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansEpigenomicsTranscriptomeOligodendrogliaCell DifferentiationDNA MethylationMyelin SheathMixed Function OxygenasesProto-Oncogene Proteins

Stichwörter der Autor:innen

Epigenetic editingEpigeneticsOligodendrocyteProgressive MS

Substanzen

TET1 protein, humanMixed Function OxygenasesProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
  • Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • University MS Center (UMSC) Hasselt, Pelt, Belgium.
  • Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, University of Exeter, Exeter, UK.
  • Stem Cell Institute, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • Fondation Charcot

Zitieren

APA

Tiane, A., Schepers, M., Reijnders, R. A., van Veggel, L., Chenine, S., Rombaut, B., Dempster, E., Verfaillie, C., Wasner, K., Grünewald, A., Prickaerts, J., Pishva, E., Hellings, N., van den Hove, D., & Vanmierlo, T. (2023). From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Acta Neuropathologica, 146(2), 283-299. https://doi.org/10.1007/s00401-023-02596-8

Vancouver

Tiane A, Schepers M, Reijnders RA, van Veggel L, Chenine S, Rombaut B, et al. From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Acta Neuropathologica. 2023;146(2):283-299. doi:10.1007/s00401-023-02596-8

BibTeX
@article{Tiane2023,
  author = {Tiane, Assia and Schepers, Melissa and Reijnders, Rick A and van Veggel, Lieve and Chenine, Sarah and Rombaut, Ben and Dempster, Emma and Verfaillie, Catherine and Wasner, Kobi and Grünewald, Anne and Prickaerts, Jos and Pishva, Ehsan and Hellings, Niels and van den Hove, Daniel and Vanmierlo, Tim},
  title = {From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions},
  journal = {Acta Neuropathologica},
  year = {2023},
  volume = {146},
  number = {2},
  pages = {283--299},
  doi = {10.1007/s00401-023-02596-8}
}
Kostenlos starten →